J. Clin. Med. 2013, 2(4), 188-200; doi:10.3390/jcm2040188
Article

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

1 Department of Surgery, Leiden University Medical Center, Albinusdreef 2, ZA Leiden 2333, The Netherlands 2 Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, ZA Leiden 2333, The Netherlands
* Author to whom correspondence should be addressed.
Received: 16 August 2013; in revised form: 5 September 2013 / Accepted: 11 September 2013 / Published: 16 October 2013
(This article belongs to the Special Issue Prevention and Treatment of Bone Metastases from Breast Cancer)
PDF Full-text Download PDF Full-Text [274 KB, uploaded 16 October 2013 16:57 CEST]
Abstract: The antitumor effect of bisphosphonates (BPs) is under increasing scrutiny. Preclinical and clinical evidence has shown that BPs might sensitize breast tumors to chemotherapy. Here, we present a review of current preclinical and clinical evidence for antitumor effects of BPs, and evaluate how BPs might play a role in neoadjuvant treatment of women with breast cancer.
Keywords: bisphosphonates; zoledronic acid; chemotherapy; neoadjuvant; postmenopausal

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Charehbili, A.; Fontein, D.B.Y.; Kroep, J.R.; Liefers, G.-J.; Nortier, J.W.R.; Velde, C.J.H. Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? J. Clin. Med. 2013, 2, 188-200.

AMA Style

Charehbili A, Fontein DBY, Kroep JR, Liefers G-J, Nortier JWR, Velde CJH. Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? Journal of Clinical Medicine. 2013; 2(4):188-200.

Chicago/Turabian Style

Charehbili, Ayoub; Fontein, Duveken B.Y.; Kroep, Judith R.; Liefers, Gerrit-Jan; Nortier, Johannes W.R.; Velde, Cornelis J.H. 2013. "Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?" J. Clin. Med. 2, no. 4: 188-200.

J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert